Apini Therapeutics Limited

Active13767202 Private limited company
Incorporated
26 November 2021 (4 years)
Industry
Research and experimental development on biotechnology (72110)
Directors
John Timothy Roger Isaac
James Gibbons
Susan Jane Herbert
Accounts type
Small
Region
East of England
Address
Burnham House Splash Lane
Wyton
Huntingdon
PE28 2AF

Filing status

Accounts due
31 December 2027
Last accounts
31 March 2026
Conf. stmt due
9 December 2026
Last conf. stmt
25 November 2025

Officers 6 active

Officer details are public data from the Companies House register.

Isaac, John Timothy Roger, Dr
Director · Appointed 7 November 2025
British
Born February 1969 (57)
Gibbons, James
Director · Appointed 27 March 2025
British
Born February 1990 (36)
Herbert, Susan Jane, Dr
Director · Appointed 3 December 2024
British
Born February 1964 (62)
Corporate Secretary · Appointed 27 September 2024
Director · Appointed 13 August 2024
French
Born April 1985 (41)
Butterworth, Sam, Dr.
Director · Appointed 26 November 2021
British
Born August 1978 (48)
Officer history (1 former)
7 November 2025
Appointed Isaac, John Timothy Roger, Dr as Director
7 November 2025
Resigned Wooster, Richard Francis as Director
27 March 2025
Appointed Gibbons, James as Director
3 December 2024
Appointed Herbert, Susan Jane, Dr as Director
27 September 2024
Appointed Archangel Accounting Limited as Corporate Secretary
13 August 2024
Appointed Dahan, Nathaniel, Dr as Director
13 August 2024
Appointed Wooster, Richard Francis as Director
26 November 2021
Appointed Butterworth, Sam, Dr. as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 13 August 2024
Owns 50–75% of shares
Holds 50–75% of voting rights
Private Limited Company
Reg. no. 15871470
Former controllers (1)
13 August 2024
Ceased Sam Butterworth — Owns 50–75% of shares

Group structure 4 companies

Ownership group derived from the Companies House PSC register

Altx Therapeutics Limited Owns 50–75% of shares
Apini Therapeutics Limited This company Owns 50–75% of shares
Slingshot Therapeutics Limited Owns 75–100% of shares

Financials

Balance sheet as at 31 March 2026 · small accounts

Cash
£1,831,238
Current Ratio
17.5x

Trend

Shareholder Funds
(£2.0M) £0 £2.0M £4.0M 2022 2023 2026 £130,007 (£100,675) £2,188,076
Balance sheet detail
202620232022
Fixed Assets£130,000£130,000
Current Assets£2,286,362£32,263£0
Debtors£455,124
Cash£1,831,238
Creditors (< 1 year)£130,786£0£0
Creditors (> 1 year)£262,945£0
Net Current Assets£2,155,576£32,263£0
Net Assets(£100,675)£130,007
Shareholder Funds£2,188,076(£100,675)£130,007

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
10 August 2026Statement of capital following an allotment of shares

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?